Search

everythinglearnresearchcommunity

for

Search:↓

Coenzyme Q10 may protect liver function but doesn't reduce hair loss from anthracycline antibiotics.

Early detection and skin biopsies are crucial for treating skin cancer and diagnosing various skin conditions.

Hair loss can indicate various health issues, including serious diseases, hormonal imbalances, and can significantly affect personal life and mental health.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

Hair follicle hyperplasia is common in both benign and malignant skin lymphoproliferative disorders, with a proposed new term "pseudolymphomatous adnexitis."

Early and accurate diagnosis of primary vitreoretinal lymphoma is crucial to prevent serious complications.

Hormone-replacement therapy improved a woman's skin condition known as lymphomatoid papulosis.

Targeting TCR-Vβ2 in cutaneous T cell lymphoma shows promise for safer, more specific treatment.

Early diagnosis and aggressive treatment are crucial for better outcomes in lymphomatoid granulomatosis.

Older patients with new retinal lesions may have cancer, and local radiation might not stop it from spreading.

Alopecia areata can be an early sign of Hodgkin’s lymphoma and may improve with lymphoma treatment.

A woman's small, unnoticed adrenal mass turned out to be a rare non-Hodgkin's lymphoma, treated successfully with surgery and therapy.

Hodgkin's lymphoma can show up as hair loss.

Abnormal Hedgehog signaling in blood cancers may help tumors grow and resist chemotherapy, suggesting potential for targeted treatments.

A 69-year-old smoker was wrongly diagnosed with lung cancer but actually had a rare lymphatic system disorder.

FDG PET/CT scans can change cancer treatment plans for dogs.

Finasteride is effective for male hair loss, teledermatology is accurate and accepted, and cyclosporin helps treat toxic epidermal necrolysis.

Folliculotropic mycosis fungoides has unique molecular features and cell interactions that could guide targeted therapy.

FDG PET/CT can improve cancer treatment plans in dogs.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Bendamustine, often combined with other drugs, is effective and less toxic for certain blood cancers, but less effective for young, fit patients with CLL.

Balancing treatment effectiveness with side effects is crucial for relapsed follicular non-Hodgkin's lymphoma, especially in older patients.

Mice with human skin protein K8 had more skin problems and cancer.

Long-standing benign tumors can become cancerous, especially in people with weakened immune systems.

The document concludes that individualized treatment for malignant epithelial tumors is necessary and more research on metastatic squamous cell carcinoma treatments is needed.

Hair and nail changes can indicate health issues, including cancer and side effects from cancer treatments.

Interferon alfa-2a is effective for treating cutaneous T cell lymphoma but has significant side effects.

Using hair dye may slightly increase the risk of non-Hodgkin's lymphoma, especially with long-term use.